Status:
COMPLETED
Optical Frequency Domain Imaging (OFDI) and Vascular Healing After Stent Placement
Lead Sponsor:
Emory University
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The use of drug eluting stents (DES) used to treat coronary artery blockages is limited by poor healing of the stented area. This will require the combined use of blood thinners such as aspirin and cl...
Detailed Description
The long-term efficacy of drug eluting stents (DES) used to treat symptomatic coronary artery disease is limited by incomplete healing of the stented segment necessitating the use of dual anti-platele...
Eligibility Criteria
Inclusion
- Any patient requiring percutaneous transluminal coronary interventions (PTCI) for acute coronary syndrome (ACS) and meeting criteria (as determined by the performing physician) for Resolute Integrity stent placement.
Exclusion
- ST segment elevation MI (STEMI)
- stable angina
- current or planned pregnancy (for women of childbearing age)
- treatment of \> 2 lesions during the index hospitalization
- insulin dependent diabetic patients at the time of stent placement
- use of overlapping stents.
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT01794949
Start Date
September 1 2013
End Date
November 1 2016
Last Update
May 15 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Hospital Midtown
Atlanta, Georgia, United States, 30308